| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| bardoxolone methyl | nf-kappa-b inhibitor alpha | small molecule | NA | drugbank | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Mixed Connective Tissue Disease[MeSHID:D008947] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pulmonary Hypertension[MeSHID:D006976] Idiopathic pulmonary arterial hypertension[MeSHID:D065627] |
NA | investigational | unknown |
| bardoxolone methyl | ppar-gamma messenger rna | NA | Literature-reported target | TTD , DGIDB | Lymphoma[MeSHID:D008223] Neoplasms[MeSHID:D009369] Multiple Myeloma[MeSHID:D009101] Mixed Connective Tissue Disease[MeSHID:D008947] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Pulmonary Hypertension[MeSHID:D006976] Idiopathic pulmonary arterial hypertension[MeSHID:D065627] |
0.12 | phase 3 | antagonist |
| click here to return to the previous page | ||||||||